Clinical trials
Hemorrhage clinical trials
Below are recruiting hemorrhage clinical trials, each written for real people, not researchers. We’re tracking 381 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07623525RecruitingPhase 1/Phase 2
DIAG723 study for hereditary hemorrhagic telangiectasia
This study tests a new drug called DIAG723 in adults with hereditary hemorrhagic telangiectasia (HHT), a genetic condition that causes abnormal blood vessels and bleeding. Depending on which part of the study you qualify for, the drug may help reduce nosebleeds, improve anemia, or help with lung blood vessel problems caused by HHT.
Camperdown, New South WalesAges 18 years+ - NCT07601425RecruitingPhase 1/Phase 2
ATV-1601 Treatment for Hereditary Hemorrhagic Telangiectasia
This trial tests a new drug called ATV-1601 in people with HHT, a genetic condition that causes abnormal bleeding and blood vessel problems. The drug aims to reduce bleeding and anemia caused by HHT.
Boston, MassachusettsAges 18 years+ - NCT07728734Enrolling by invitation
Predicting recovery after a brain bleed
This study is testing a way to predict how well people will recover after a brain bleed (intracerebral hemorrhage). It uses information from the first 24 hours to help doctors and families understand the chances of getting better.
Badalona, BarcelonaAges 18 years+ - NCT06999122Recruiting
Testing a new helmet-style brain scanner for stroke bleeding
This trial tests a new type of brain scanner (similar to a helmet) that looks for bleeding in the brain without radiation. It is for people who have had stroke-like symptoms in the last 24 hours and have not yet received treatment.
Los Angeles, CaliforniaAges 22 years+ - NCT06513351Recruiting
Predicting postpartum bleeding after delivery
This trial tests a way to predict heavy bleeding after childbirth. It includes people having a vaginal or cesarean delivery and aims to help doctors prepare for and prevent complications.
Nashville, TennesseeAges Any age - NCT07712198Recruiting
AI predicts muscle loss risk in brain injury ICU patients
This study uses artificial intelligence to predict which brain injury patients in the intensive care unit are at risk for muscle loss (sarcopenia). It aims to help doctors identify and prevent this complication early.
TrabzonAges 18–65 - NCT03245866Recruiting
Study for bleeding caused by a brain aneurysm rupture
This study is for people admitted with a confirmed brain bleeding caused by a ruptured aneurysm. The goal is to better understand this specific cause of bleeding, which may help improve care for patients with aneurysm-related subarachnoid hemorrhage.
Aarau, Canton of AargauAges Any age - NCT03318432Recruiting
Stroke recovery research registry for people with ongoing symptoms
This study is a registry that enrolls adults who have had a stroke and still have symptoms. It helps researchers learn about stroke recovery over time and may connect you to future stroke research studies.
San Francisco, CaliforniaAges 18 years+ - NCT03696680RecruitingPhase 2
Stereotactic radiation for brain metastases that recently bled
This trial tests a precise type of radiation aimed at brain metastases that show signs of recent bleeding. It aims to control the tumors while reducing risks, especially compared with the usual approach for patients who have bleeding signals in the brain lesions.
AvranchesAges 18 years+ - NCT03936361RecruitingPhase 3
Statins after a stroke bleed in the brain (Phase 3)
This trial studies whether continuing or stopping statin medicine after a spontaneous bleeding stroke in the brain (called lobar ICH) leads to better outcomes. It may help clarify if statins are safer to stay on—or better to pause—after this type of event.
Boston, MassachusettsAges 50 years+ - NCT03990558Recruiting
Testing ways to improve waking after a brain bleed
This trial studies treatments to help people regain consciousness after an intracerebral hemorrhage (a bleeding stroke inside the brain). It focuses on adults who are unresponsive to commands within 48 hours, likely from certain bleeding locations, and who meet specific safety and language requirements.
Miami, FloridaAges 18 years+ - NCT07701512RecruitingPhase 2
Febuxostat for brain bleed patients managed without surgery
This trial tests if febuxostat, a medicine used for gout, can help people recover from a brain bleed (intracranial hemorrhage) when surgery is not needed. It may reduce inflammation and improve outcomes.
Al Mansurah, Dakahlia GovernorateAges 18 years+ - NCT04449666Recruiting
Brain scan and memory testing after bleeding from a brain aneurysm
This trial uses brain MRI scans and memory/brain-function tests in people who are recovering from a specific type of brain bleed (aneurysmal subarachnoid hemorrhage). It aims to understand how the brain’s memory area changes after the event and how that may relate to memory function during rehabilitation.
Hessisch OldendorfAges 18–70 - NCT04459806Recruiting
Study dose timing to improve care for brain injury
This trial studies how to time medication or treatment doses when a person has serious brain injury, using measurements from a pressure monitor in the skull. It may help doctors manage brain swelling and pressure more effectively.
Monza, MBAges 18–80 - NCT04469517Recruiting
Study of low-oxygen factors in hereditary bleeding disorder
This study looks at how “low-oxygen” signals may affect people with hereditary hemorrhagic telangiectasia (HHT), a genetic bleeding disorder. It may help researchers understand what drives symptoms and could guide future treatments.
Essen, North Rhine-WestphaliaAges 18 years+ - NCT04507178RecruitingPhase 2
Nadroparine to improve recovery after bleeding in the brain
This study tests whether nadroparine (a blood-thinning medicine) can improve outcomes after a type of brain bleed called subarachnoid hemorrhage. It focuses on people who have had a brain aneurysm treated with a procedure soon after the bleed.
AmsterdamAges 18 years+ - NCT04557618Recruiting
Ear nerve stimulation after a brain bleed
This trial studies whether stimulating a nerve near the ear (auricular VNS) can help after a spontaneous subarachnoid hemorrhage, a type of bleeding around the brain. If you qualify, you may receive the ear stimulation as an added treatment while doctors monitor your recovery.
St Louis, MissouriAges 18 years+ - NCT04566991RecruitingPhase 2
Deferoxamine after aneurysm brain bleed to improve recovery
This trial studies deferoxamine, a medicine that targets iron-related injury, in people with an aneurysmal subarachnoid hemorrhage (a brain bleed caused by a burst aneurysm). It aims to improve neurologic recovery after the aneurysm is treated.
Ann Arbor, MichiganAges 18–80 - NCT04624295RecruitingPhase 4
Aspirin soon after certain bleeding stroke, after clot-busting therapy
This trial studies whether starting aspirin early is safe and helpful for people who, after clot-busting treatment for an ischemic stroke, develop a specific type of small brain bleeding called hemorrhagic infarction. You might benefit if your scan later shows this pattern of bleeding and you are not able to take blood-thinners or aspirin is safe for you.
HangzhouAges Any age - NCT04696523RecruitingPhase 2
Xenon gas for brain injury after a ruptured brain aneurysm
This Phase 2 study tests whether xenon gas can reduce brain injury after an aneurysmal subarachnoid hemorrhage (a bleeding caused by a brain aneurysm). It aims to help people who are very sick right after the bleeding by improving brain function outcomes.
Helsinki, HelsinkiAges 18 years+ - NCT04707105Recruiting
Study of brain bleeding in hospitalized adults
This study follows adults who are hospitalized after a type of brain bleed called primary intracerebral hemorrhage. It mainly tracks what happens after the bleeding to help doctors understand outcomes and care needs.
Hangzhou, ZhejiangAges 18 years+ - NCT04785976Recruiting
Study of long-term outcomes after a ruptured brain aneurysm bleed
This trial is a long-term follow-up study of people who come to the emergency room with a ruptured brain aneurysm (bleeding in the space around the brain). It helps doctors understand what outcomes are most common and what may affect recovery over time.
Beijing, Beijing MunicipalityAges Any age - NCT04916210Recruiting
Study how stroke type affects thinking and recovery
This study looks at what predicts memory and thinking problems after different types of stroke or brain bleeding, and how blood-vessel changes relate to recovery. You may be invited if you recently had a stroke/bleed and can complete a baseline check within 6 weeks.
Phoenix, ArizonaAges 18 years+ - NCT04976036RecruitingPhase 2
Nintedanib to reduce nosebleeds in adults with HHT
This trial tests whether nintedanib can reduce how often and how severe nosebleeds are in adults with hereditary hemorrhagic telangiectasia (HHT). It may help by calming blood-vessel problems that cause bleeding.
BronAges 18 years+
Hear when a new Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hemorrhage?
- Yes. Clin2 currently lists 381 recruiting hemorrhage studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hemorrhage trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hemorrhage trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.